Analystreport

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) had its "neutral" rating re-affirmed by analysts at UBS AG. They now have a $20.00 price target on the stock, up previously from $12.00.

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com